Satellos Bioscience MSLE
NASDAQ MSLE
$6.42 -0.20 (-3.02%)
At close: Oct 23, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Cash & Current Investments (2023 - 2026)

Updated

Satellos Bioscience (MSLE) posted Cash & Current Investments of $61.84 million for the quarter ended Jun 30, 2026, down 11.5% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Cash & Current Investments (2023 - 2026) Analysis & Trends

As of Dec 31, 2024, Satellos Bioscience's Cash & Current Investments came in at $50 million, up 208.5% from the prior year.

  • In prior years, Satellos Bioscience's Cash & Current Investments was $16.21 million in the year ended Dec 31, 2023.
  • The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Cash & Current Investments since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Satellos Bioscience 99.25 Mn -108.89 Mn - 61.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.84 Mn
Mar 31, 2026 69.91 Mn
Dec 31, 2025 27.71 Mn
Dec 31, 2024 48.68 Mn
Dec 31, 2023 16.68 Mn
API Access

Satellos Bioscience Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MSLE&period=max&api_key=YOUR_API_KEY